Cargando…
Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and β-Secretase 1: Next Generation for Alzheimer’s Disease Treatment
Alzheimer’s Disease (AD) is a neurodegenerative condition characterized by progressive memory loss and other affected cognitive functions. Pharmacological therapy of AD relies on inhibitors of the enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), offering only a palliative effect...
Autores principales: | Mendes, Géssica Oliveira, Pita, Samuel Silva da Rocha, de Carvalho, Paulo Batista, da Silva, Michel Pires, Taranto, Alex Gutterres, Leite, Franco Henrique Andrade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302529/ https://www.ncbi.nlm.nih.gov/pubmed/37375827 http://dx.doi.org/10.3390/ph16060880 |
Ejemplares similares
-
Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
por: Pohanka, Miroslav, et al.
Publicado: (2013) -
Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014) -
Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011) -
Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies
por: de Almeida, Raquel B. M., et al.
Publicado: (2023) -
Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin
por: Kumar, Suresh
Publicado: (2015)